Skip to main content
. 2015 Dec 18;16(12):30321–30341. doi: 10.3390/ijms161226232

Table 2.

Phenotypes of cFLIP gene-manipulated mice.

Genotype/Organ Phenotype References
Whole body KO mice Cflip−/− Embryonic lethality [82]
Cflip-l+46 mutant Embryonic lethality [83]
Cflip−/−Ripk3−/− Embryonic lethality [84]
Cflip−/−Fadd−/−Ripk3−/− Normal development [84]
Conditional KO mice T cells Increased cell death [85,86,87,88]
B cells Increased cell death [89,90]
Myeloid lineage Growth retardation, Splenomegaly [91,92]
Dendritic cells Increased inflammation [93,94]
Liver Increased liver failure [95,96,97,98,99,100]
Intestine Increased cell death and inflammation [95,101]
Skin epidermis Increased cell death and inflammation [102,103]
Transgenic mice cFLIPR in Cflip-deficient T cells Similar to Cflip-deficient T cells [104,105]
cFLIPL in T cells Increased survival [106,107,108,109,110,111,112,113,114,115]
cFLIPS in T cells Increased survival [116,117]
cFLIPL in neuron Increased survival [118]
cFLIPL in thyroid Better resolution from autoimmune disease [119,120,121,122]
cFLIPL in heart Reduced cardiac hypertrophy, prevention of cardiac remodeling [123,124,125]
cFLIPL in eosinophil Increased survival [126]
cFLIPL in testis Testis atrophy [127]
cFLIPL in muscle Muscle aging [128]
cFLIPR in hematopoietic cells Better bacterial clearance, increased autoimmune disease [129,130]